The overexpression of MTBP can accelerate the metabolism and clearance of sorafenib in HCC cells and tissues while the knocking down of MTBP expression can prolong the retention time of sorafenib in HCC cells and tissues. The gene discussed is MTBP; the disease is hepatocellular carcinoma.